Stay updated on PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial page.

Latest updates to the PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision entry v3.6.3 was added to the study record history, and the previous revision v3.6.2 was removed.SummaryDifference0.1%

- Check23 days agoChange Detected- The study record history now includes a new revision entry Revision: v3.6.2 and removes the older Revision: v3.6.0, updating the visible version history.SummaryDifference0.1%

- Check38 days agoChange DetectedThe study history now shows recruitment has ceased (no longer looking for participants) and a new revision entry v3.6.0 was added, replacing the previous revision v3.5.5 in the history.SummaryDifference0.5%

- Check45 days agoChange DetectedA new release revision v3.5.5 was added to the study history, replacing the previous v3.5.4.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page history shows a new site revision v3.5.4 replacing v3.5.3, indicating a deployment of the latest interface update. It does not modify the study information or core page content.SummaryDifference0.1%

- Check80 days agoChange DetectedA new revision entry v3.5.3 has been added to the history, replacing the previous v3.5.2 entry. This change reflects an update to the page's revision metadata rather than changes to the study content.SummaryDifference0.1%

Stay in the know with updates to PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial page.